MEDIFAST INC (MED)vsRollins Inc (ROL)
MED
MEDIFAST INC
$12.04
-0.08%
CONSUMER CYCLICAL · Cap: $141.66M
ROL
Rollins Inc
$34.73
+0.49%
CONSUMER CYCLICAL · Cap: $16.82B
Smart Verdict
WallStSmart Research — data-driven comparison
Rollins Inc generates 1138% more annual revenue ($3.92B vs $316.93M). ROL leads profitability with a 13.6% profit margin vs -8.1%. MED appears more attractively valued with a PEG of 0.97. ROL earns a higher WallStSmart Score of 52/100 (C-).
MED
Hold45
out of 100
Grade: D
ROL
Buy52
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for MED.
Margin of Safety
+49.1%
Fair Value
$67.90
Current Price
$34.73
$33.17 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Conservative balance sheet, low leverage
Growing faster than its price suggests
Every $100 of equity generates 37 in profit
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -10.1% — below average capital efficiency
Revenue declined 27.6%
Premium valuation, high expectations priced in
Trading at 11.7x book value
3.1% earnings growth
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : MED
The strongest argument for MED centers on Price/Book, Altman Z-Score, Debt/Equity. PEG of 0.97 suggests the stock is reasonably priced for its growth.
Bull Case : ROL
The strongest argument for ROL centers on Return on Equity.
Bear Case : MED
The primary concerns for MED are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : ROL
The primary concerns for ROL are P/E Ratio, Price/Book, EPS Growth.
Key Dynamics to Monitor
MED profiles as a turnaround stock while ROL is a value play — different risk/reward profiles.
ROL carries more volatility with a beta of 0.74 — expect wider price swings.
ROL is growing revenue faster at 7.9% — sustainability is the question.
ROL generates stronger free cash flow (166M), providing more financial flexibility.
Bottom Line
ROL scores higher overall (52/100 vs 45/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
MEDIFAST INC
CONSUMER CYCLICAL · PERSONAL SERVICES · USA
Medifast, Inc. manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutrition products in the United States and Asia-Pacific. The company is headquartered in Baltimore, Maryland.
Visit Website →Rollins Inc
CONSUMER CYCLICAL · PERSONAL SERVICES · USA
Rollins, Inc. is a North American consumer and commercial services company.
Visit Website →Compare with Other PERSONAL SERVICES Stocks
Want to dig deeper into these stocks?